scispace - formally typeset
M

Martin Radolf

Researcher at Research Institute of Molecular Pathology

Publications -  10
Citations -  1319

Martin Radolf is an academic researcher from Research Institute of Molecular Pathology. The author has contributed to research in topics: Gene & Transcription factor. The author has an hindex of 8, co-authored 10 publications receiving 1212 citations.

Papers
More filters
Journal ArticleDOI

The profile of repeat‐associated histone lysine methylation states in the mouse epigenome

TL;DR: A profile of repressive histone lysine methylation states for the repetitive complement of four distinct mouse epigenomes is defined and tandem repeats and dsRNA are suggested as primary triggers for more stable chromatin imprints.
Journal ArticleDOI

Systematic genetic analysis of muscle morphogenesis and function in Drosophila

TL;DR: A role in muscle is identified for 2,785 genes, many of which are phylogenetically conserved, including genes implicated in mammalian sarcomere organization and human muscle diseases.
Journal ArticleDOI

Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome.

TL;DR: M mammalian chromosome arms contain active chromatin interspersed with repressive chromatin resembling the type of heterochromatin previously considered a feature of centromeres, telomeres, and the inactive X chromosome.
Journal ArticleDOI

Spalt mediates an evolutionarily conserved switch to fibrillar muscle fate in insects

TL;DR: It is proposed that Spalt proteins switch myofibres from tubular to fibrillar fate during development, a function potentially conserved in the vertebrate heart—a stretch-activated muscle sharing features with insect flight muscle.
Journal ArticleDOI

Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.

TL;DR: Data show that a single Jun/c-Fos dimer is sufficient for osteoclast differentiation, likely due to its transactivation ability for a broader range of promoters, in particular consensus AP-1 sites.